Number of the records: 1

ipilimumab

Subject h.	ipilimumab
Subject h.	Ipilimumab
Entry terms	anti-CTLA-4 MAb ipilimumab MDX 010 MDX-CTLA-4
Scope note in English	An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
Pharmacology effect	antineoplastiká imunologické inhibítory imunitných kontrolných bodov
Pharmacology effect	Antineoplastic Agents, Immunological Immune Checkpoint Inhibitors
See also reference (FX) in Slovak	antigén CTLA-4
See also reference (FX) in English	CTLA-4 Antigen
Links	(11) - ARTICLES
	(1) - MeSH descriptor
	(3) - CiBaMed

subject heading

Number of the records: 1